Mathilde Latil
- Aging top 10%
- Rehabilitation top 5%
- Genetics top 10%
- Mesenchymal stem cell research 2
- Molecular Biology top 10%
- Muscle Physiology and Disorders 6
- Retinoids in leukemia and cellular processes 2
-
- Retinal Diseases and Treatments 5
-
- Cancer-related Molecular Pathways 3
- Cancer Cells and Metastasis 2
-
- SARS-CoV-2 and COVID-19 Research 2
- COVID-19 Clinical Research Studies 2
Mathilde Latil
20 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Aging 24
- Rehabilitation 93
- Critical Care and Intensive Care Medicine 69
- Genetics 141
- Molecular Biology 781
Countries citing papers authored by Mathilde Latil
This map shows the geographic impact of Mathilde Latil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathilde Latil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathilde Latil more than expected).
Fields of papers citing papers by Mathilde Latil
This network shows the impact of papers produced by Mathilde Latil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathilde Latil. The network helps show where Mathilde Latil may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mathilde Latil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | RHOJ controls EMT-associated resistance to chemotherapybreakdown → | 2023 | 104 |
| 3 | 2023 | 4 | |
| 4 | 2023 | 10 | |
| 5 | 2021 | 20 | |
| 6 | 2021 | 27 | |
| 7 | 2021 | 16 | |
| 8 | 2021 | 5 | |
| 9 | 2020 | 19 | |
| 10 | 2020 | 9 | |
| 11 | 2019 | 27 | |
| 12 | 2019 | 1 | |
| 13 | 2019 | 2 | |
| 14 | 2016 | 151 | |
| 15 | 2016 | 355 | |
| 16 | 2015 | 162 | |
| 17 | 2015 | 139 | |
| 18 | 2015 | 1 | |
| 19 | 2013 | 69 | |
| 20 | 2012 | 106 |
About Mathilde Latil
Mathilde Latil is a scholar working on Ophthalmology, Genetics, Behavioral Neuroscience, Critical Care and Intensive Care Medicine and Oncology, having authored 20 papers that have together received 1.2k indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (6 papers), Retinal Diseases and Treatments (5 papers), Cancer-related Molecular Pathways (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Mesenchymal stem cell research (2 papers), COVID-19 Clinical Research Studies (2 papers), Cancer Cells and Metastasis (2 papers) and Retinoids in leukemia and cellular processes (2 papers). The work is most often cited by research in Aging (24 citations), Rehabilitation (93 citations), Critical Care and Intensive Care Medicine (69 citations), Genetics (141 citations) and Molecular Biology (781 citations). Mathilde Latil has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Fabrice Chrétien, Pierre Rocheteau, Cédric Blanpain, Shahragim Tajbakhsh, Dany Nassar, David Briand, Grégory Jouvion, Bram Boeckx, Diether Lambrechts and Barbara Gayraud-Morel. Their work appears in journals such as Nature Communications, Aging, International Journal of Molecular Sciences, Neuromuscular Disorders and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.